Determination of Mechanical Properties of Concrete by Destructive and Non-Destructive Experimental Methods

This paper examines the mechanical quality differences of concrete by destructive and non destructive methods according to shape, dimension relationship and cure conditions. Within destructive methods, (compression, tension, bending) different shaped-sized concretes and 28-days-old concrete shear wall samples tested along to find modulus of elasticity. Non destructive methods (ultrasonic pulse velocity test, rebound hammer test) applied same samples along to determine compressive strength and longitudinal wave velocity to obtain result of modulus of elasticity. The aim was to achieve data from applied laboratory test results and cross-checking, all values to enhance concretes compressive strength for potential possibilities

Design and manufacture of a rear driveline package including limited slip differential for Formula SAE applications

Thesis (S.B.)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 2008.Includes bibliographical references (p. 66).This document describes the design and manufacture of a lightweight rear driveline package for a Formula SAE race car. The design focuses on all components needed to transfer power from the chain driven Honda CBR600 F4i to the rear drive wheels, and includes a custom limited slip differential housing, drive shafts, hubs, and wheels. The design is centered on a custom aluminum housing for Torsen@ T1 gears, which provides limited slip and torque biasing between the two drive wheels. This type of differential has proven itself in the world of motorsports, especially in the Formula SAE series. This document demonstrates the design concepts and justifications, as well as the manufacturing processes needed to fabricate the designs. This work on the driveline package was developed with the hopes that it will be used in future years as a stepping stone for improved designs. Design choices and justifications have been explained, and manufacturing processes have been thoroughly described through the use of both text and figures to aid in the manufacture of future components. TORSEN® is a registered trademark of Toyoda-Koki Automotive Torsen North America Inc.by Tolga T. Yazicioglu.S.B

Lung Transplantation for Primary Ciliary Dyskinesia and Kartagener Syndrome: A Multicenter Study.

Primary ciliary dyskinesia, with or without situs abnormalities, is a rare lung disease that can lead to an irreversible lung damage that may progress to respiratory failure. Lung transplant can be considered in end-stage disease. This study describes the outcomes of the largest lung transplant population for PCD and for PCD with situs abnormalities, also identified as Kartagener's syndrome. Retrospectively collected data of 36 patients who underwent lung transplantation for PCD from 1995 to 2020 with or without SA as part of the European Society of Thoracic Surgeons Lung Transplantation Working Group on rare diseases. Primary outcomes of interest included survival and freedom from chronic lung allograft dysfunction. Secondary outcomes included primary graft dysfunction within 72 h and the rate of rejection ≥A2 within the first year. Among PCD recipients with and without SA, the mean overall and CLAD-free survival were 5.9 and 5.2 years with no significant differences between groups in terms of time to CLAD (HR: 0.92, 95% CI: 0.27-3.14, p = 0.894) or mortality (HR: 0.45, 95% CI: 0.14-1.43, p = 0.178). Postoperative rates of PGD were comparable between groups; rejection grades ≥A2 on first biopsy or within the first year was more common in patients with SA. This study provides a valuable insight on international practices of lung transplantation in patients with PCD. Lung transplantation is an acceptable treatment option in this population

Extreme geomagnetic field variability indicated by Eastern Mediterranean full-vector archaeomagnetic records

The magnetic field of the Earth can exhibit considerable variations at short time scales, even as short as decades. The archaeomagnetic studies of Middle Eastern artefacts (mainly from Israel and Jordan) show evidence for an exceptionally high intensity period from 1050-700 BC which displays two distinct spikes over the Levant, the Levantine Iron Age Anomaly (LIAA). Its exact duration and geographical extent are still poorly known. Despite the wealth of ancient settlements, the extensive cultural heritage and a long history of trade and immigration, the archaeomagnetism of Turkey and Cyprus remains largely unexplored. This study presents a large data set of ancient directions and intensities from seven archaeological sites in the Eastern Mediterranean covering a time span of ∼2000 yrs. The recorded directions from thirteen sets of samples are coherent with our earlier findings, yet show significantly larger swings than existing field models. In particular, we confirm the very large swing in inclination we found earlier, from 1910-1850 BC, that is also captured by the Greek PSV curve, and shallower by more than 10° than predicted by existing field models. Consequently, these models require substantial revision in this region. We were able to determine the archaeointensity from five sets of mud-bricks, from the thirteen attempted, allowing us to provide the full field vector. Furthermore, we present thirty-one new archaeointensity results from potsherds and mud-bricks that considerably enhance existing data, especially when a set of strict selection criteria is applied. Fourteen sets of potsherds from a single site (Tell Atchana) provide the longest sequence recorded so far in Turkey, from 2100 to 1350 BC. We find exceptionally high intensities of 145 and 175 ZAm2 around 700 BC, in well-dated mud-bricks and potsherds from two different locations (Tell Tayinat and Kilise Tepe), supporting extreme geomagnetic field variability in the region. Moreover, these two high intensities confirm the younger spike of the LIAA in Turkey

The N-Terminal Domain of ERK1 Accounts for the Functional Differences with ERK2

The Extracellular Regulated Kinase 1 and 2 transduce a variety of extracellular stimuli regulating processes as diverse as proliferation, differentiation and synaptic plasticity. Once activated in the cytoplasm, ERK1 and ERK2 translocate into the nucleus and interact with nuclear substrates to induce specific programs of gene expression. ERK1/2 share 85% of aminoacid identity and all known functional domains and thence they have been considered functionally equivalent until recent studies found that the ablation of either ERK1 or ERK2 causes dramatically different phenotypes. To search a molecular justification of this dichotomy we investigated whether the different functions of ERK1 and 2 might depend on the properties of their cytoplasmic-nuclear trafficking. Since in the nucleus ERK1/2 is predominantly inactivated, the maintenance of a constant level of nuclear activity requires continuous shuttling of activated protein from the cytoplasm. For this reason, different nuclear-cytoplasmic trafficking of ERK1 and 2 would cause a differential signalling capability. We have characterised the trafficking of fluorescently tagged ERK1 and ERK2 by means of time-lapse imaging in living cells. Surprisingly, we found that ERK1 shuttles between the nucleus and cytoplasm at a much slower rate than ERK2. This difference is caused by a domain of ERK1 located at its N-terminus since the progressive deletion of these residues converted the shuttling features of ERK1 into those of ERK2. Conversely, the fusion of this ERK1 sequence at the N-terminus of ERK2 slowed down its shuttling to a similar value found for ERK1. Finally, computational, biochemical and cellular studies indicated that the reduced nuclear shuttling of ERK1 causes a strong reduction of its nuclear phosphorylation compared to ERK2, leading to a reduced capability of ERK1 to carry proliferative signals to the nucleus. This mechanism significantly contributes to the differential ability of ERK1 and 2 to generate an overall signalling output

Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review

Atrial Fibrillation (AF) is the most common arrhythmia occurring after cardiac surgery. Its incidence varies depending on type of surgery. Postoperative AF may cause hemodynamic deterioration, predispose to stroke and increase mortality. Effective treatment for prophylaxis of postoperative AF is vital as reduces hospitalization and overall morbidity. Beta - blockers, have been proved to prevent effectively atrial fibrillation following cardiac surgery and should be routinely used if there are no contraindications. Sotalol may be more effective than standard b-blockers for the prevention of AF without causing an excess of side effects. Amiodarone is useful when beta-blocker therapy is not possible or as additional prophylaxis in high risk patients. Other agents such as magnesium, calcium channels blocker or non-antiarrhythmic drugs as glycose-insulin - potassium, non-steroidal anti-inflammatory drugs, corticosteroids, N-acetylcysteine and statins have been studied as alternative treatment for postoperative AF prophylaxis